Marais, S; Van Toorn, R; Chow, FC; Manesh, A; Siddiqi, OK; Figaji, A; Schoeman, JF; ... Wilkinson, RJ; + view all Marais, S; Van Toorn, R; Chow, FC; Manesh, A; Siddiqi, OK; Figaji, A; Schoeman, JF; Meintjes, G; Aarnoutse, RE; Anderson, STB; Bahr, NC; Bang, ND; Boulware, DR; Boyles, T; te Brake, LHM; Chandra, S; Cresswell, FV; van Crevel, R; Davis, AG; Dian, S; Donovan, J; Dooley, KE; Rizal, AG; Garg, RK; Gibb, DM; Hamers, RL; Hiep, NTT; Imran, D; Imron, A; Jain, SK; Jain, SK; Jeejeebhoy, B; Kalita, J; Kumar, R; Kumar, V; van Laarhoven, A; Lai, RPJ; Mave, V; Meya, DB; Misra, UK; Modi, M; Ordonez, AA; Phu, NH; Pradhan, S; Prasad, K; Proust, AM; Ramakrishnan, L; Rohlwink, U; Ruslami, R; Seddon, JA; Sharma, K; Siddiqi, O; Solomons, RS; Thuong, NTT; Thwaites, GE; van Toorn, R; Tucker, EW; Wasserman, SA; Wilkinson, RJ; - view fewer (2019) Management of intracranial tuberculous mass lesions: How long should we treat for? [version 2; peer review: 1 approved, 2 approved with reservations]. Wellcome Open Research , 4 , Article 158. 10.12688/wellcomeopenres.15501.1.